Trinity Biotech | TRIB - Selling And Administration Expenses


Trinity Biotech reported $6.19M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Bio-Rad Laboratories USD 206.8M 900K Sep/2025
EDAP TMS EUR 8.81M 1.57M Sep/2025
J&J USD 6.75B 831M Dec/2025
Mesa Laboratories USD 27.31M 380K Sep/2024
OraSure Technologies USD 13.21M 3.29M Dec/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Siemens EUR 3.61B 489M Dec/2025
Surmodics USD 11.4M 3.18M Jun/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Tosoh JPY 41.52B 2.62B Dec/2025
Trinity Biotech USD 6.19M 2.18M Sep/2025
Veracyte USD 43.31M 8.43M Dec/2025